Explore why INmune Bio, Inc. is a speculative Strong Buy for high-risk investors. Click for the upcoming catalysts that make ...

Maple Leaf shares are attractively priced, and the firm has a catalyst in the form of its pending spinoff. Read why I rate ...

Chronic refractory pain poses a significant challenge in knee joint pathologies, especially after exhaustion of conservative, ...

It is now illegal to publish or threaten to publish real or AI-generated intimate images of a person without their consent. Tech sites and companies also must take down such images within 48 hours of ...

In the case of PSMU, someone might feel bad if they are unable to access social media for an extended period (withdrawal), or ...

PITTSBURGH, May 29, 2025 /PRNewswire/ -- Koppers Holdings Inc. (NYSE: KOP ), a leading integrated global provider of treated ...

Former sales employee of Amref flying doctors said his image was used without his consent and without compensation on Twitter and Facebook. • Gedion Nyaga said the photos were rightly understood ...

New data show that lecanemab is well tolerated outside of clinical trial setting, with expected and manageable side effects.

Explore top Speechify alternatives offering natural-sounding AI voices, flexible features and better value for content ...

The "Piers Morgan Uncensored" host shares his opinions on President Trump, President Biden, and Meghan Markle and Prince Harry with TheWrap ...

Table 1 presents a summary of risk factors for falls identified from studies undertaken in people with cognitive impairment and ... each factor with a four-level rating system according to the ...

Australia's Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of ...